Target intelligence / Profile preview

Long intergenic non-protein coding RNA 893 (LINC00893)

Target
LINC00893
Molecular classification
Long non-coding RNA (lncRNA), Non-coding RNA, Other
01

Overview

Long intergenic non-protein coding RNA 893 (LINC00893), also known as EOLA1 divergent transcript (EOLA1-DT), is a member of the long non-coding RNA (lncRNA) class. These transcripts are over 200 nucleotides in length and do not code for proteins, but can regulate gene expression locally or at a distance in the genome[2]. Divergent lncRNAs are transcribed in close genomic proximity and in the opposite direction to adjacent protein-coding genes, often participating in transcriptional and epigenetic regulation[1]. The alias "CRC progression-associated lncRNA" suggests that LINC00893/EOLA1-DT may be involved in colorectal cancer, although its biological role, mechanisms, and potential as a biomarker or target remain largely uncharacterized in current literature. No drugs, direct mechanisms of action, or safety issues have been documented for this target[2][3].

Other names
EOLA1 divergent transcriptLINC00893lnc-CPLCgene WCRC progression-associated lncRNALong intergenic non-protein coding RNA 893
02

Biological functions

Regulation of gene expressionEpigenetic regulationPotential modulation of chromatin structureMay play roles in transcriptional regulation, especially of adjacent genes
03

Disease associations

Cancer (colorectal cancer progression association inferred from alias)Other (potentially in cell proliferation and differentiation, as is general for many lncRNAs)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 893 (LINC00893).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 893 (LINC00893).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call